[go: up one dir, main page]

WO2006112867A8 - Profil d'expression genique dans une micromatrice dans des classes d'hypernephrome papillaire - Google Patents

Profil d'expression genique dans une micromatrice dans des classes d'hypernephrome papillaire

Info

Publication number
WO2006112867A8
WO2006112867A8 PCT/US2005/020840 US2005020840W WO2006112867A8 WO 2006112867 A8 WO2006112867 A8 WO 2006112867A8 US 2005020840 W US2005020840 W US 2005020840W WO 2006112867 A8 WO2006112867 A8 WO 2006112867A8
Authority
WO
WIPO (PCT)
Prior art keywords
cell carcinoma
renal cell
expression profiling
classes
gene expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/020840
Other languages
English (en)
Other versions
WO2006112867A3 (fr
WO2006112867A2 (fr
Inventor
Bin Tean Teh
Minhan Tan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Van Andel Research Institute
Original Assignee
Van Andel Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Van Andel Research Institute filed Critical Van Andel Research Institute
Publication of WO2006112867A2 publication Critical patent/WO2006112867A2/fr
Publication of WO2006112867A8 publication Critical patent/WO2006112867A8/fr
Publication of WO2006112867A3 publication Critical patent/WO2006112867A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention porte sur une sonde d'acide nucléique ou sur un nouvel ensemble de ces sondes dans une micromatrice. La sonde ou un ensemble de sondes est utile dans le pronostique de patients atteints d'un hypernéphrome papillaire dans lequel des types de tumeur agressive et non agressive sont caractérisées par des profils d'expression différentielle des gènes qui s'hybride à une ou plusieurs de ces sondes. L'invention porte également sur des micromatrices et sur des kits pour réaliser le profil d'expression d'un tissu tumoral et sur leurs méthodes d'utilisation.
PCT/US2005/020840 2005-04-18 2005-06-13 Profil d'expression genique dans une micromatrice dans des classes d'hypernephrome papillaire Ceased WO2006112867A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USPCT/US05/013260 2005-04-18
PCT/US2005/013260 WO2006112842A2 (fr) 2005-04-18 2005-04-18 Profilage d'expression genique par microreseau dans des classes de carcinome cellulaire renal papillaire

Publications (3)

Publication Number Publication Date
WO2006112867A2 WO2006112867A2 (fr) 2006-10-26
WO2006112867A8 true WO2006112867A8 (fr) 2007-01-04
WO2006112867A3 WO2006112867A3 (fr) 2007-02-15

Family

ID=37115597

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2005/013260 Ceased WO2006112842A2 (fr) 2005-04-18 2005-04-18 Profilage d'expression genique par microreseau dans des classes de carcinome cellulaire renal papillaire
PCT/US2005/020840 Ceased WO2006112867A2 (fr) 2005-04-18 2005-06-13 Profil d'expression genique dans une micromatrice dans des classes d'hypernephrome papillaire

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2005/013260 Ceased WO2006112842A2 (fr) 2005-04-18 2005-04-18 Profilage d'expression genique par microreseau dans des classes de carcinome cellulaire renal papillaire

Country Status (1)

Country Link
WO (2) WO2006112842A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2680339C (fr) 2007-03-08 2017-02-28 F. Hoffmann-La Roche Ag Utilisation de slim-1 dans l'evaluation d'une insuffisance cardiaque
WO2011073402A1 (fr) * 2009-12-17 2011-06-23 Oslo Universitetssykehus Hf Variants de transcription de vnn1 et slc39a14
BR112016008202A2 (pt) * 2013-10-23 2017-10-03 Univ Oregon Health & Science Métodos de determinação do prognóstico do câncer de mama
WO2024050547A2 (fr) * 2022-09-02 2024-03-07 Hunterian Medicine Llc Promoteurs bidirectionnels compacts pour expression génique

Also Published As

Publication number Publication date
WO2006112842A2 (fr) 2006-10-26
WO2006112842A9 (fr) 2007-02-15
WO2006112842A8 (fr) 2007-03-29
WO2006112842A3 (fr) 2009-04-16
WO2006112867A3 (fr) 2007-02-15
WO2006112867A2 (fr) 2006-10-26

Similar Documents

Publication Publication Date Title
WO2002079411A3 (fr) Etablissement de profils d'expression genique dans un microreseau dans un adenocarcinome a cellules claires, pronostic et identification de cible medicamenteuse
JP7717608B2 (ja) メチル化核酸の高深度シーケンシングのための方法とシステム
Keller et al. Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
Locke et al. DNA methylation cancer biomarkers: translation to the clinic
Vriens et al. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer
Yan et al. Novel fusion transcripts associate with progressive prostate cancer
AU2025202411A1 (en) Methods, compositions, kits and devices for rapid analysis of biological markers
Schepeler et al. Diagnostic and prognostic microRNAs in stage II colon cancer
Barefoot et al. Detection of cell types contributing to cancer from circulating, cell-free methylated DNA
Dong et al. DNA methylation as an early diagnostic marker of cancer
EP2861759B1 (fr) Biomarqueurs pour le cancer de la prostate
WO2011056489A3 (fr) Méthodes de diagnostic permettant d'établir un pronostic en cas de cancer du poumon non à petites cellules
Zhu et al. Use of DNA methylation for cancer detection: promises and challenges
CN113151458A (zh) 实体瘤甲基化标志物及其用途
Wang et al. Identification of biomarkers for the detection of early stage lung adenocarcinoma by microarray profiling of long noncoding RNAs
JP2024020392A (ja) 特定の遺伝子のｃｐｇメチル化変化を利用した肝癌診断用組成物およびその使用
CN102782151A (zh) 作为用于前列腺癌诊断和分期的非侵入性标志物的循环miRNA
EP3789496B1 (fr) Test de méthylation d'adn pour le cancer de la prostate
Macerola et al. NanoString in the screening of genetic abnormalities associated with thyroid cancer
WO2019041045A1 (fr) Profilage et traitement d'un cancer hypermutant
WO2006112867A8 (fr) Profil d'expression genique dans une micromatrice dans des classes d'hypernephrome papillaire
García-Giménez et al. Epigenetic biomarkers for disease diagnosis
WO2014057279A1 (fr) Biomarqueurs de microarn pour le cancer de la prostate
Foekens et al. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine
Kristiansen et al. Methylated DNA for monitoring tumor growth and regression: how do we get there?

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 05771565

Country of ref document: EP

Kind code of ref document: A2